Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Management of Ischemic Heart Disease With Angiwell-XR (Ranolazine)

NCT03486561 is registered in ClinicalTrials.gov with OBS Pakistan as lead sponsor.

NCT NCT03486561
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03486561 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Management of Ischemic Heart Disease With Angiwell-XR (Ranolazine)
Lead sponsor
OBS Pakistan
Phase
Phase 4
Overall status
Unknown status
Start date
April 1, 2018
Completion date
October 31, 2018
Enrollment
2,000 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chronic stable angina